Ampio Pharmaceuticals (NYSE:AMPE) Coverage Initiated by Analysts at StockNews.com

StockNews.com started coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE) in a research note released on Wednesday morning. The brokerage issued a sell rating on the stock.

Ampio Pharmaceuticals Stock Performance

NYSE:AMPE opened at $0.00 on Wednesday. The stock has a 50 day simple moving average of $0.01 and a 200 day simple moving average of $0.03. Ampio Pharmaceuticals has a 1-year low of $0.00 and a 1-year high of $2.91. The stock has a market cap of $2,951.00, a P/E ratio of 0.00 and a beta of 3.67.

About Ampio Pharmaceuticals

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.